908 Devices Inc.

NasdaqGM MASS

908 Devices Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2024

908 Devices Inc. Interest Coverage Ratio is NA for the Trailing 12 Months (TTM) ending September 30, 2024. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • 908 Devices Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2023 was -41.81, a 83.36% change year over year.
  • 908 Devices Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2022 was -251.20, a -512.89% change year over year.
  • 908 Devices Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2021 was -40.99, a -1,792.00% change year over year.
  • 908 Devices Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2020 was -2.17.
Key data
Date Interest Coverage Ratio Debt to Equity Ratio Interest Expense To Sales Inventory Turnover Ratio
Market news
Loading...
SV Wall Street
NasdaqGM: MASS

908 Devices Inc.

CEO Dr. Kevin J. Knopp Ph.D.
IPO Date Dec. 18, 2020
Location United States
Headquarters 645 Summer Street
Employees 230
Sector Technology
Industries
Description

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Similar companies

MGRM

Monogram Orthopaedics, Inc.

USD 2.78

-2.46%

CNMD

CONMED Corporation

USD 67.36

-8.97%

INMD

InMode Ltd.

USD 18.25

1.62%

DXCM

DexCom, Inc.

USD 88.32

-0.52%

EW

Edwards Lifesciences Corporation

USD 70.99

-1.54%

SYK

Stryker Corporation

USD 396.07

-0.76%

NVRO

Nevro Corp.

USD 5.72

13.94%

ABT

Abbott Laboratories

USD 128.22

-2.91%

MDT

Medtronic plc

USD 90.82

-0.95%

NARI

Inari Medical, Inc.

USD 79.87

-0.03%

BSX

Boston Scientific Corporation

USD 105.02

0.05%

GKOS

Glaukos Corporation

USD 155.28

-1.17%

BFLY

Butterfly Network, Inc.

USD 4.40

-2.22%

StockViz Staff

February 7, 2025

Any question? Send us an email